S M Parsons
Overview
Explore the profile of S M Parsons including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
814
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Batteiger D, Parsons S
Neurochem Int
. 2010 May;
8(2):249-53.
PMID: 20493054
The ATPase in synaptic vesicles isolated from Torpedo californica electric organ can be nearly completely solubilized in octaethyleneglycoldodecyl ether containing buffer where it is stable only in a narrow pH...
2.
Efange S, von Hohenberg K , Khare A, Tu Z, Mach R, Parsons S
Nucl Med Biol
. 2001 Jan;
27(8):749-55.
PMID: 11150707
The vesamicol analogue (+/-)-trans-2-Hydroxy-3-[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM), a potent ligand for the vesicular acetylcholine transporter (VAChT), was evaluated as a potential radiotracer for studying VAChT density in vivo. In radioligand binding experiments,...
3.
Johnson J, Rhee J, Parsons S, Brown D, Olson E, Rawls A
Dev Biol
. 2001 Jan;
229(1):176-87.
PMID: 11133162
Establishing the anterior/posterior (A/P) boundary of individual somites is important for setting up the segmental body plan of all vertebrates. Resegmentation of adjacent sclerotomes to form the vertebrae and selective...
4.
Parsons S
FASEB J
. 2000 Dec;
14(15):2423-34.
PMID: 11099460
Sequence-related vesicular acetylcholine transporter (VAChT) and vesicular monoamine transporter (VMAT) transport neurotransmitter substrates into secretory vesicles. This review seeks to identify shared and differentiated aspects of the transport mechanisms. VAChT...
5.
Hagopian J, Kirtley M, Stevenson L, Gergis R, Russo A, Pavletich N, et al.
J Biol Chem
. 2000 Oct;
276(1):275-80.
PMID: 11029468
The activation of most protein kinases requires phosphorylation at a conserved site within a structurally defined segment termed the activation loop. A classic example is the regulation of the cell...
6.
Keller J, Bravo D, Parsons S
J Neurochem
. 2000 Mar;
74(4):1739-48.
PMID: 10737633
Properties of cysteinyl residues in the vesicular acetylcholine transporter (VAChT) of synaptic vesicles isolated from Torpedo californica were probed. Cysteine-specific reagents of different size and polarity were used and the...
7.
Keller J, Parsons S
Neurochem Int
. 2000 Feb;
36(2):113-7.
PMID: 10676874
The role of proton binding sites in the vesicular acetylcholine transporter was investigated by characterization of the pH dependence for the binding of [3H]vesamicol [(-)-trans-2-(4-phenylpiperidino)cyclohexanol] to Torpedo synaptic vesicles. A...
8.
Khare A, Langason R, Parsons S, Mach R, Efange S
Nucl Med Biol
. 1999 Dec;
26(6):609-17.
PMID: 10587098
Four isomeric N-(halophenyl)trozamicol analogues (6a-d) were synthesized and evaluated as potential vesicular acetylcholine transporter (VAChT) ligands. Of the four compounds, N-(3-bromophenyl) trozamicol (6b) and N-(3-iodophenyl)trozamicol (6d) displayed the highest affinity...
9.
Wilson-Rawls J, Hurt C, Parsons S, Rawls A
Development
. 1999 Nov;
126(23):5217-29.
PMID: 10556048
In vertebrates, skeletal muscle is derived from progenitor cell populations located in the epithelial dermomyotome compartment of the each somite. These cells become committed to the myogenic lineage upon delamination...
10.
Clarizia A, Gomez M, Romano-Silva M, Parsons S, Prado V, Prado M
Neuroreport
. 1999 Oct;
10(13):2783-7.
PMID: 10511440
4-Aminobenzovesamicol was used to test whether activation of protein kinase C protects the vesicular acetylcholine transporter from interaction with vesamicol-like drugs. The essentially irreversible vesamicol analog inhibits the release of...